🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Asst. Prof Tim Guetterman et al examined verbal & nonverbal communication between docs & #Cancer patients to help docs respond to emotions, exchange info, make decisions, foster healing relationships, enable patient self-management & manage uncertainty. bit.ly/3X9ili5

Chief of urological oncology Todd 〽️ Morgan, MD recently went on the BackTable Urology podcast to talk about germline testing for #prostatecancer patients. 👂🔗 michmed.org/Z7yQN

Thank you Ninja and BeardedBlevins - we’re excited!

🎮 | Thursday, on September 5, watch live as Ninja and BeardedBlevins, take on the virtual battlefield from the Big House, all in aid of U-M Rogel Cancer Center. Your donations will fuel innovative cancer research! 💪 Join us & donate here: victors.us/blevinsbrothers

Chief of urological oncology Todd 〽️ Morgan, MD recently went on the BackTable Urology podcast to talk about germline testing for #prostatecancer patients. 👂🔗 michmed.org/Z7yQN

👏Congratulations! 5 UMich RNA Center 〽️🧬 faculty members honored in 2024 Class of Rogel Scholars. Innovative scientists and clinicians at the forefront of cancer research and treatment. Read more👉rna.umich.edu/five-faculty-m… U-M Rogel Cancer Center Michigan Medicine Analisa DiFeo Justin Colacino Deepak Nagrath Lab

A #prostatecancer diagnosis brings up many uncertainties. The care team at the Weiser Center for Prostate Cancer treats the whole patient. Offering individualized care and addressing concerns. Learn more at below 📹 and visit weiserprostatecancer.org

Chief of urological oncology Todd 〽️ Morgan, MD recently went on the BackTable Urology podcast to talk about germline testing for #prostatecancer patients. 👂🔗 michmed.org/Z7yQN

Good morning from The Big House! Set-up is underway for The Blevins Brothers Family Fortnite Friday Charity Stream benefiting the U-M Rogel Cancer Center! Join us at 10am EST with Ninja and BeardedBlevins! victors.us/blevinsbrothers

Super cool event for a really awesome cause. Check it out this AM, and if you can, help.

Thanks for joining us this morning and sharing your personal cancer story Davis Warren! #GoBlue #BeatCancer #BeatTexas

“Magic happens here on Saturdays. Magic happens at the U-M Rogel Cancer Center Center every day.” — Alex Orji

The Weiser Center for #ProstateCancer provides a patient experience navigator. She is the “hub” of the care team and is with patients from day one. Find out more about the #personalcare offered: weiserprostatecancer.org

Rogel researchers found AR binds with the protein NSD2, it causes rapid cell division and growth leading to prostate cancer. It could be a potential therapeutic target: michmed.org/reZq2 #ChinnaiyanLab Abhijit Parolia Nature Genetics

How does the androgen receptor regulate normal prostate development but also prostate cancer? This Nature Genetics study is one of the first molecular explanations for this functional duality: michmed.org/reZq2 Abhijit Parolia #ChinnaiyanLab Michigan Pathology

The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for cancer patients prescribed oral chemotherapy, reports new study in JAMA Network Open: michmed.org/z4mkR Ben Pockros Kristian Stensland, MD MPH U-M IHPI

A new study finds efforts to cap prescription drug spending could save cancer patients more than $7,200 a year in out-of-pocket spending. Ben Pockros U-M IHPI JAMA Network Open Full paper: jamanetwork.com/journals/jaman… Summary: michmed.org/z4mkR

The Weiser Center for #ProstateCancer provides a patient experience navigator. She is the “hub” of the care team and is with patients from day one. Find out more about the #personalcare offered: weiserprostatecancer.org

When the protein NSD2 is present, it rearranges where the androgen receptor enhanceosome sits on the DNA, setting it next to sites occupied by known cancer-causing genes and drivers. It could be an indirect therapeutic target for prostate cancer: michmed.org/reZq2

For Medicare Part D beneficiaries, annual out-of-pocket costs for oral cancer medications averaged $11,284 in 2023 and are estimated to be $3,927 in 2024 with new spending caps, new study from Ben Pockros et al finds: michmed.org/z4mkR